Provided by Tiger Trade Technology Pte. Ltd.

Anaptysbio Inc

55.63
-1.4000-2.45%
Volume:426.61K
Turnover:24.32M
Market Cap:1.65B
PE:-61.49
High:58.09
Open:56.82
Low:55.63
Close:57.03
52wk High:73.30
52wk Low:17.11
Shares:29.61M
Float Shares:21.05M
Volume Ratio:1.98
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9047
EPS(LYR):-0.4601
ROE:-114.55%
ROA:6.78%
PB:129.22
PE(LYR):-120.90

Loading ...

Stock Track | AnaptysBio Plummets 5.37% Intraday as Risks from Proposed Breakup Weigh on Shares

Stock Track
·
Mar 05

Analysts’ Top Healthcare Picks: Oculis Holding (OCS), AnaptysBio (ANAB)

TIPRANKS
·
Mar 05

U.S. RESEARCH ROUNDUP-Broadcom, CNX Resources, Veeva Systems

Reuters
·
Mar 05

Risks Loom for AnaptysBio’s Proposed Breakup: Market Value, Volatility and Execution Challenges Highlighted

TIPRANKS
·
Mar 05

AnaptysBio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 05

BUZZ-U.S. STOCKS ON THE MOVE-AnaptysBio, Tesla, Intel

Reuters
·
Mar 05

BUZZ-AnaptysBio climbs on plans to split into two public companies

Reuters
·
Mar 05

AnaptysBio Is Maintained at Overweight by Barclays

Dow Jones
·
Mar 04

Stock Track | Anaptysbio Soars 6.15% Intraday on Multiple Analyst Target Price Hikes

Stock Track
·
Mar 04

AnaptysBio Inc : Wedbush Raises Target Price to $60 From $50

THOMSON REUTERS
·
Mar 04

AnaptysBio Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 04

Wedbush Raises Price Target on AnaptysBio to $60 From $50, Keeps Outperform Rating

MT Newswires Live
·
Mar 04

AnaptysBio : Barclays Raises Target Price to $79 From $78

THOMSON REUTERS
·
Mar 04

AnaptysBio price target raised to $66 from $51 at H.C. Wainwright

TIPRANKS
·
Mar 04

U.S. RESEARCH ROUNDUP-CrowdStrike, Oracle, Vulcan Materials

Reuters
·
Mar 04

AnaptysBio to Spin Off Biopharma Portfolio

Dow Jones
·
Mar 04

AnaptysBio Q4 Swings to Profit, Revenue Rises

MT Newswires Live
·
Mar 04

AnaptysBio's Q4 collaboration revenue more than doubled; details spin-off plan

Reuters
·
Mar 04

AnaptysBio provides update on potential spin-off of biopharma operations

TIPRANKS
·
Mar 04

BRIEF-AnaptysBio Q4 Net Income USD 49.614 Million

Reuters
·
Mar 04